Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling
Treatment of melanoma with a BRAF inhibitor (BRAFi) frequently initiates development of BRAFi resistance, leading to increased tumor progression and metastasis. Previously, we showed that combined inhibition of elevated WNT5A and IL-6 signaling reduced the invasion and migration of BRAFi-resistant (...
Main Authors: | Vikas Yadav, Njainday Jobe, Shakti Ranjan Satapathy, Purusottam Mohapatra, Tommy Andersson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/24/6077 |
Similar Items
-
WNT5A-Induced Activation of the Protein Kinase C Substrate MARCKS Is Required for Melanoma Cell Invasion
by: Purusottam Mohapatra, et al.
Published: (2020-02-01) -
Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?
by: Chandra Prakash Prasad, et al.
Published: (2015-09-01) -
The Role of MARCKS in Metastasis and Treatment Resistance of Solid Tumors
by: Chun-Lung Chiu, et al.
Published: (2022-10-01) -
Augmentation of Cathepsin Isoforms in Diabetic db/db Mouse Kidneys Is Associated with an Increase in Renal MARCKS Expression and Proteolysis
by: Mohammed F. Gholam, et al.
Published: (2023-08-01) -
Charles Marck, Sur les routes que j’ai parcourues
by: Laurence Montel
Published: (2022-10-01)